echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Cancer: The risk and related factors of post-traumatic stress disorder in patients with acute myeloid leukemia during intensive chemotherapy

    Cancer: The risk and related factors of post-traumatic stress disorder in patients with acute myeloid leukemia during intensive chemotherapy

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Acute myeloid leukemia (AML) patients undergoing intensive chemotherapy not only face life-threatening diseases, require isolation and hospitalization, but also have many physical and psychological symptoms .


    Acute myeloid leukemia (AML) patients receiving intensive chemotherapy not only face life-threatening diseases, need to be isolated and hospitalized, but also have many physical and psychological symptoms

    Amonoo et al.


    Among the 160 patients, 28% reported PTSD symptoms , and had a high rate of invasion, evasion, and high alertness.


    28% of patients reported PTSD symptoms

    The incidence of PTSD symptoms in patients with different coping styles

    The incidence of PTSD symptoms in patients with different coping styles

    The baseline sociodemographic factors significantly related to PTSD symptoms were age (B=-0.


    The baseline sociodemographic factors significantly related to PTSD symptoms were age (B=-0.


    The patient’s baseline quality of life, coping strategies, and the degree of decline in quality of life during hospitalization are all important risk factors for post-traumatic stress disorder

    Original source:

    Original source:

    Amonoo Hermioni L, LeBlanc Thomas W, Kavanaugh Alison R et al.


    org/10.
    1002/cncr.
    33524" target="_blank" rel="noopener">Posttraumatic stress disorder (PTSD) symptoms in patients with acute myeloid leukemia (AML) in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.